{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T17:15:25Z","timestamp":1784135725962,"version":"3.55.0"},"reference-count":55,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The cartilage oligomeric matrix protein (COMP) and Golgi-protein-73 (GP73) have been proposed as markers of liver fibrosis and hepatocellular carcinoma (HCC). Our aim was to assess the performance of the combination of these markers in diagnosing cirrhosis and predicting HCC development. Sera from 288 consecutive patients with chronic liver diseases were investigated by using COMP and GP73-ELISAs. Dual positivity for COMP (&gt;15 U\/L) and GP73 (&gt;20 units) was observed in 24 (8.3%) patients, while 30 (10.4%) were GP73(+)\/COMP(\u2212), 37\/288 (12.8%) GP73(\u2212)\/COMP(+), and 197 (68.5%) GP73(\u2212)\/COMP(\u2212). Positivity for both markers was associated with cirrhosis [23\/24 (95.8%) for GP73(+)\/COMP(+) vs. 22\/30 (73.3%) for GP73(+)\/COMP(\u2212) vs. 25\/37 (67.6%) for GP73(\u2212)\/COMP(+) vs. 46\/197 (23.4%) for GP73(\u2212)\/COMP(\u2212); P &lt; 0.001]. The combination of GP73, COMP, the aspartate aminotransferase\/platelets ratio index, and the Fibrosis-4 score had even higher diagnostic accuracy to detect the presence of cirrhosis [AUC (95% CI): 0.916 (0.878\u20130.946)] or significant liver fibrosis (METAVIR \u2265 F2) [AUC (95% CI): 0.832 (0.768\u20130.883)] than each marker alone. Kaplan-Meier analysis showed that positivity for both GP73 and COMP was associated with higher rates of HCC development (P &lt; 0.001) and liver-related deaths (P &lt; 0.001) during follow-up. In conclusion, the combination of GP73 and COMP seems efficient to detect cirrhosis and predict worse outcomes and the development of HCC in patients with chronic liver diseases.<\/jats:p>","DOI":"10.3390\/cancers13143510","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T22:25:31Z","timestamp":1626215131000},"page":"3510","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Serum Cartilage Oligomeric Matrix Protein and Golgi Protein-73: New Diagnostic and Predictive Tools for Liver Fibrosis and Hepatocellular Cancer?"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3715-8640","authenticated-orcid":false,"given":"Nikolaos K.","family":"Gatselis","sequence":"first","affiliation":[{"name":"Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, 41110 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalliopi","family":"Zachou","sequence":"additional","affiliation":[{"name":"Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, 41110 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Giannoulis","sequence":"additional","affiliation":[{"name":"Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, 41110 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4779-8155","authenticated-orcid":false,"given":"Stella","family":"Gabeta","sequence":"additional","affiliation":[{"name":"Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, 41110 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8992-1866","authenticated-orcid":false,"given":"Gary L.","family":"Norman","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Inova Diagnostics, Inc., San Diego, CA 92131, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George N.","family":"Dalekos","sequence":"additional","affiliation":[{"name":"Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, 41110 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jhep.2019.08.025","article-title":"Epidemiology and surveillance for hepatocellular carcinoma: New trends","volume":"72","author":"Singal","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","article-title":"Epidemiology and Management of Hepatocellular Carcinoma","volume":"156","author":"Kulik","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular Carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_4","unstructured":"European Association for the Study of the Liver (2018). EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J. Hepatol., 69, 182\u2013236."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"European Association for Study of the Liver (2015). EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J. Hepatol., 63, 237\u2013264.","DOI":"10.1016\/j.jhep.2015.04.006"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/apt.15533","article-title":"Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response","volume":"50","author":"Hirschfield","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ctrv.2018.05.006","article-title":"Systemic therapy for intermediate and advanced hepatocellular carcinoma: Sorafenib and beyond","volume":"68","author":"Raoul","year":"2018","journal-title":"Cancer Treat Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"Liver biopsy","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhep.2008.10.014","article-title":"Liver biopsy: The best, not the gold standard","volume":"50","author":"Bedossa","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient elastography: A new noninvasive method for assessment of hepatic fibrosis","volume":"29","author":"Sandrin","year":"2003","journal-title":"Ultrasound Med. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"100285","DOI":"10.1016\/j.aohep.2020.10.013","article-title":"FibroMeter scores for the assessment of liver fibrosis in patients with autoimmune liver diseases","volume":"22","author":"Zachou","year":"2021","journal-title":"Ann. Hepatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.3748\/wjg.v24.i35.3974","article-title":"Biomarkers for hepatocellular carcinoma: What\u2019s new on the horizon?","volume":"24","author":"Ocker","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.3748\/wjg.v26.i34.5130","article-title":"Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients","volume":"26","author":"Gatselis","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.4254\/wjh.v7.i14.1875","article-title":"Cartilage oligomeric matrix protein: A novel non-invasive marker for assessing cirrhosis and risk of hepatocellular carcinoma","volume":"7","author":"Norman","year":"2015","journal-title":"World J. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejim.2017.01.007","article-title":"COMP serum levels: A new non-invasive biomarker of liver fibrosis in patients with chronic viral hepatitis","volume":"38","author":"Zachou","year":"2017","journal-title":"Eur. J. Intern. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1016\/j.ejim.2017.05.003","article-title":"Cartilage oligomeric matrix protein on the spot for liver fibrosis evaluation: Too early or too late?","volume":"43","author":"Zachou","year":"2017","journal-title":"Eur. J. Intern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/jvh.12786","article-title":"Assessment of serum Golgi protein 73 as a biomarker for the diagnosis of significant fibrosis in patients with chronic HBV infection","volume":"24","author":"Cao","year":"2017","journal-title":"J. Viral. Hepat."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"6036904","DOI":"10.1155\/2020\/6036904","article-title":"Serum Golgi Protein 73 as a Potential Biomarker for Hepatic Necroinflammation in Population with Nonalcoholic Steatohepatitis","volume":"2020","author":"Wang","year":"2020","journal-title":"Dis. Markers"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e12538","DOI":"10.1111\/cpr.12538","article-title":"Golgi protein 73 and its diagnostic value in liver diseases","volume":"52","author":"Xia","year":"2019","journal-title":"Cell Prolif."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jhep.2016.06.003","article-title":"Cartilage oligomeric matrix protein participates in the pathogenesis of liver fibrosis","volume":"65","author":"Magdaleno","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3109\/23744235.2015.1075659","article-title":"Cartilage oligomeric matrix protein: A new promising biomarker of liver fibrosis in chronic hepatitis C","volume":"47","author":"Andreasson","year":"2015","journal-title":"Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1440-1746.2003.03268.x","article-title":"Cartilage oligomeric matrix protein expression in hepatocellular carcinoma and the cirrhotic liver","volume":"19","author":"Xiao","year":"2004","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0962-8924(97)01197-5","article-title":"Localization of proteins to the Golgi apparatus","volume":"8","author":"Munro","year":"1998","journal-title":"Trends Cell Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0378-1119(00)00136-0","article-title":"GP73, a novel Golgi-localized protein upregulated by viral infection","volume":"249","author":"Kladney","year":"2000","journal-title":"Gene"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/2045-3701-2-31","article-title":"Golgi phosphoprotein 2 in physiology and in diseases","volume":"2","author":"Kim","year":"2012","journal-title":"Cell Biosci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.jhep.2020.01.007","article-title":"Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B","volume":"72","author":"Papatheodoridis","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Dalekos, G.N., Azariadis, K., Lygoura, V., Arvaniti, P., Gampeta, S., and Gatselis, N.K. (2021). Autoimmune hepatitis in patients aged 70 years or older: Disease characteristics, treatment response and outcome. Liver Int.","DOI":"10.1111\/liv.14900"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","article-title":"Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C","volume":"128","author":"Castera","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/hep.24268","article-title":"Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality","volume":"53","author":"Younossi","year":"2011","journal-title":"Hepatology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: An updated meta-analysis","volume":"53","author":"Lin","year":"2011","journal-title":"Hepatology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/hep.27382","article-title":"Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: A systemic review and meta-analysis","volume":"61","author":"Xiao","year":"2015","journal-title":"Hepatology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1515\/CCLM.2011.640","article-title":"Golgi protein 73(GP73), a useful serum marker in liver diseases","volume":"49","author":"Liu","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s12016-017-8655-y","article-title":"The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature Review","volume":"54","author":"Yao","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1572-0241.2004.30572.x","article-title":"Disease- and cell-specific expression of GP73 in human liver disease","volume":"99","author":"Iftikhar","year":"2004","journal-title":"Am. J. Gastroenterol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1053\/jhep.2002.32525","article-title":"Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease","volume":"35","author":"Kladney","year":"2002","journal-title":"Hepatology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/jmv.25045","article-title":"Predictive value of serum Golgi protein 73 for prominent hepatic necroinflammation in chronic HBV infection","volume":"90","author":"Xu","year":"2018","journal-title":"J. Med. Virol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"16498","DOI":"10.18632\/oncotarget.14954","article-title":"Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1515\/CCLM.2011.097","article-title":"A comparative evaluation of Golgi protein-73, fucosylated hemopexin, alpha-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma","volume":"49","author":"Morota","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.clinbiochem.2014.08.010","article-title":"Serum gp73 is also a biomarker for diagnosing cirrhosis in population with chronic HBV infection","volume":"47","author":"Qiao","year":"2014","journal-title":"Clin. Biochem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.diagmicrobio.2014.01.008","article-title":"GP73, a new marker for diagnosing HBV-ACLF in population with chronic HBV infections","volume":"79","author":"Wei","year":"2014","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3862024","DOI":"10.1155\/2019\/3862024","article-title":"Exploring the Diagnostic Potential of Serum Golgi Protein 73 for Hepatic Necroinflammation and Fibrosis in Chronic HCV Infection with Different Stages of Liver Injuries","volume":"2019","author":"Qian","year":"2019","journal-title":"Dis. Markers"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1111\/liv.13536","article-title":"Algorithm of Golgi protein 73 and liver stiffness accurately diagnoses significant fibrosis in chronic HBV infection","volume":"37","author":"Cao","year":"2017","journal-title":"Liver Int."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1016\/S0021-9258(18)42671-3","article-title":"Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage","volume":"267","author":"Hedbom","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00296-006-0117-4","article-title":"Serum levels of cartilage oligomeric matrix protein (COMP): A rapid decrease in patients with active rheumatoid arthritis undergoing intravenous steroid treatment","volume":"26","author":"Skoumal","year":"2006","journal-title":"Rheumatol. Int."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4137\/BMI.S645","article-title":"Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis","volume":"4","author":"Tseng","year":"2009","journal-title":"Biomark. Insights"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fphar.2016.00159","article-title":"Non-invasive markers of liver fibrosis: Adjuncts or alternatives to liver biopsy?","volume":"7","author":"Chin","year":"2016","journal-title":"Front. Pharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Pi\u00f1ero, F., Dirchwolf, M., and Pess\u00f4a, M.G. (2020). Biomarkers in hepatocellular carcinoma: Diagnosis, prognosis and treatment response assessment. Cells, 9.","DOI":"10.3390\/cells9061370"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.21037\/atm-20-5798","article-title":"Combination of biomarkers for the detection of hepatocellular carcinoma","volume":"8","author":"Eilard","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/hep.22859","article-title":"SAFE biopsy: A validated method for large-scale staging of liver fibrosis in chronic hepatitis C","volume":"6","author":"Sebastiani","year":"2009","journal-title":"Hepatology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"536","DOI":"10.21037\/atm.2020.02.89","article-title":"The diagnostic value of the combination of Golgi-protein 73, glypican-3 and alpha-fetoprotein in hepatocellular carcinoma: A diagnostic meta-analysis","volume":"8","author":"Zhao","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jhep.2014.02.029","article-title":"Prospective evaluation of FibroTest(R), FibroMeter(R), and HepaScore(R) for staging liver fibrosis in chronic hepatitis B: Comparison with hepatitis C","volume":"61","author":"Leroy","year":"2014","journal-title":"J. Hepatol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/14\/3510\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:30:00Z","timestamp":1760164200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/14\/3510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,13]]},"references-count":55,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["cancers13143510"],"URL":"https:\/\/doi.org\/10.3390\/cancers13143510","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,13]]}}}